499
Participants
Start Date
September 1, 2018
Primary Completion Date
March 25, 2022
Study Completion Date
July 2, 2024
ClotTriever
Thrombectomy
NYU Langone Medical Center, New York
Columbia University Irving Medical Center, New York
Northwell Health, Staten Island
Albany Medical College, Albany
SUNY, The University at Buffalo, Buffalo
Allegheny Health Network Research Institute, Pittsburgh
Thomas Jefferson, Philadelphia
MedStar Health Research Institution, Washington D.C.
Sentara Vascular Specialists, Norfolk
Prisma Health - Upstate, Greenville
Longstreet Clinic, Gainesville
Memorial Hospital Jacksonville, Jacksonville
Mount Sinai Medical Center of Florida, Miami Beach
AdventHealth Tampa, Tampa
Lakeland Vascular Institute, Lakeland
Manatee Memorial Hospital, Bradenton
St. Vincent's East, Birmingham
Affinity Cardiovascular Specialists, Birmingham
Methodist Healthcare Foundation, Germantown
Surgical Care Associates, Louisville
The Christ Hospital, Cincinnati
Mercy Health - The Heart Institute, Fairfield
Beaumont Health, Royal Oak
Millenium Cardiology, Farmington Hills
Ascension Genesys Hospital, Grand Blanc
McLaren Bay Heart and Vascular, Bay City
Aurora St. Luke's Medical Center, Milwaukee
Gunderson Health, La Crosse
Washington University at St. Louis, St Louis
Saint Luke's Hospital of Kansas City, Lee's Summit
University of Missouri, Columbia
Wesley Medical Center, Wichita
Lafayette General, Lafayette
Opelousas General, Opelousas
Oklahoma Heart Institute, Tulsa
Houston Healthcare Medical Center, Houston
University of Texas Health Sciences Center - Houston, Houston
University of Colorado, Denver, Denver
University of California, Los Angeles, Los Angeles
Vascular and Interventional Specialists of Orange County, Orange
Providence Sacred Heart, Spokane
Yale University, New Haven
Hackensack Meridian, Hackensack
Lead Sponsor
Inari Medical
INDUSTRY